Retrospective Study of Severe Atopic Disease in Young Children (0–5 Years) Managed with Dupilumab Highlights Significant Comorbidities
Our findings reveal infrequently reported high rates of atopic and neurologic comorbidities in young children with AD and underscore the importance of coordinated inter-specialty collaboration to ensure timely access to dupilumab for these patients.
Authors
- Elena B. Hawryluk (ORCID: https://orcid.org/0000-0002-0862-3339)
- Evelyn Fagan (ORCID: https://orcid.org/0000-0003-2467-204X)
- Ladonya Jackson (ORCID: https://orcid.org/0000-0002-8723-7240)
Institutions
- University of Miami (US)
- Mercer University (US)
- Mercer University Health Sciences Center (US)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- Children
- Published
- 2025-12-02
- DOI
- https://doi.org/10.3390/children12121639
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Massachusetts General Hospital